-
Je něco špatně v tomto záznamu ?
The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities
M. Rašková, L. Lacina, Z. Kejík, A. Venhauerová, M. Skaličková, M. Kolář, M. Jakubek, D. Rosel, K. Smetana, J. Brábek
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-03-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
36429126
DOI
10.3390/cells11223698
Knihovny.cz E-zdroje
- MeSH
- interleukin-6 metabolismus MeSH
- lidé MeSH
- nádory * farmakoterapie MeSH
- protinádorové látky * terapeutické užití MeSH
- signální transdukce MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-κB) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.
BIOCEV 1st Faculty of Medicine Charles University 252 50 Vestec Czech Republic
BIOCEV Faculty of Science Charles University 252 50 Vestec Czech Republic
Centre for Tumour Ecology 1st Faculty of Medicine Charles University 120 00 Prague Czech Republic
Department of Cell Biology Faculty of Science Charles University 120 00 Prague Czech Republic
Institute of Anatomy 1st Faculty of Medicine Charles University 120 00 Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032615
- 003
- CZ-PrNML
- 005
- 20230131151804.0
- 007
- ta
- 008
- 230120s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cells11223698 $2 doi
- 035 __
- $a (PubMed)36429126
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Rašková, Magdalena $u Department of Cell Biology, Faculty of Science, Charles University, 120 00 Prague, Czech Republic $u BIOCEV, Faculty of Science, Charles University, 252 50 Vestec, Czech Republic
- 245 14
- $a The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities / $c M. Rašková, L. Lacina, Z. Kejík, A. Venhauerová, M. Skaličková, M. Kolář, M. Jakubek, D. Rosel, K. Smetana, J. Brábek
- 520 9_
- $a Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-κB) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a protinádorové látky $x terapeutické užití $7 D000970
- 650 _2
- $a interleukin-6 $x metabolismus $7 D015850
- 650 12
- $a nádory $x farmakoterapie $7 D009369
- 650 _2
- $a signální transdukce $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Lacina, Lukáš $u Centre for Tumour Ecology, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic $u Institute of Anatomy, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic $u Department of Dermatovenereology, First Faculty of Medicine, Charles University and General University Hospital, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000217509933
- 700 1_
- $a Kejík, Zdeněk $u Centre for Tumour Ecology, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000222154890
- 700 1_
- $a Venhauerová, Anna $u BIOCEV, Faculty of Science, Charles University, 252 50 Vestec, Czech Republic
- 700 1_
- $a Skaličková, Markéta $u BIOCEV, Faculty of Science, Charles University, 252 50 Vestec, Czech Republic
- 700 1_
- $a Kolář, Michal $u Centre for Tumour Ecology, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics, Czech Academy of Sciences, 140 00 Prague, Czech Republic $1 https://orcid.org/0000000245931525
- 700 1_
- $a Jakubek, Milan $u Centre for Tumour Ecology, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000173233903
- 700 1_
- $a Rosel, Daniel $u Department of Cell Biology, Faculty of Science, Charles University, 120 00 Prague, Czech Republic $u BIOCEV, Faculty of Science, Charles University, 252 50 Vestec, Czech Republic $1 https://orcid.org/0000000172218672
- 700 1_
- $a Smetana, Karel $u Centre for Tumour Ecology, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic $u Department of Dermatovenereology, First Faculty of Medicine, Charles University and General University Hospital, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000278788403
- 700 1_
- $a Brábek, Jan $u Department of Cell Biology, Faculty of Science, Charles University, 120 00 Prague, Czech Republic $u BIOCEV, Faculty of Science, Charles University, 252 50 Vestec, Czech Republic $1 https://orcid.org/0000000177547299
- 773 0_
- $w MED00194911 $t Cells $x 2073-4409 $g Roč. 11, č. 22 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36429126 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151759 $b ABA008
- 999 __
- $a ok $b bmc $g 1891399 $s 1183950
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 11 $c 22 $e 20221121 $i 2073-4409 $m Cells $n Cells $x MED00194911
- LZP __
- $a Pubmed-20230120